Initial urinary albumin excretion determines the progression of microalbuminuria in patients with type-2 diabetes and normotensive blood pressure values despite improved metabolic control

Diabetes Research and Clinical Practice

Volumn 39, Issue 1, 1998, Pages 39-45

  Eibl, N ^a   Schnack, Ch ^a   Frank, M ^a   Schernthaner, G ^a  

^a Rudolfstiftung   (Austria)

Author keywords

Hypertension; Metabolic control; Microalbuminuria; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT FAILURE;

AGED; ALBUMINURIA; BLOOD PRESSURE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0031969848     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00120-4     Document Type: Article

References (33)

1. Allawi J., Jarrett R.J. Microalbuminuria and cardiovascular risk factors in type-II diabetes mellitus. Diabetic Med. 7:1990;115-118.
2. Jarrett R.J., Viberti G.C., Argyropoulos A., Hill R.D., Mahmud U., Murrells T.J. Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabetic Med. 1:1984;17-19.
3. Mogensen et al. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. New Engl. J. Med. 310:1984;356-360.
4. Mattock M.B., Morrish N., Viberti G., Keen H., Fitzgerald A., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741.
5. Bangstad H.J., Østerby R., Dahl-Jørgensen K., Berg K.J., Hartmann A., Hanssen K.F. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia. 37:1994;483-490.
6. Dahl-Jørgensen K., Hanssen K.F., Kierulf P., Bjoro T., Sandvik L., Aagenaes O. Reduction of urinary albumin excretion after 4 years of continuos subcutaneous insulin infusion in insulin dependent diabetes mellitus. The Oslo study. Acta Endocrinol. 117:1988;19-25.
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329:1993;977-986.
8. Schmitz A., Hvid Hansen H., Christensen T. Kidney function in newly diagnosed type-2 (non-insulin-dependent) diabetic patients before and during treatment. Diabetologia. 32:1989;434-439.
9. Vora J.P., Dolben J., Williams J.D., Peters J.R., Owens D.R. Impact of initial treatment on renal function in newly diagnosed Type-2 diabetes mellitus. Diabetologia. 36:1993;734-740.
10. Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28:1995;103-117.
11. MacLeod J.M., Lutale J., Mashall S.M. Albumin excretion and vascular deaths in NIDDM. Diabetologia. 38:1995;610-616.
12. Viberti G.C., Bilous R.W., Mackintosh D., Bending J.J., Keen H. Long term correction of hyperglycemia and progression of renal failure in insulin dependent diabetes. Br. Med. J. 286:1984;598-602.
13. Jungmann E., Carlberg C., Schallmayer M., Schumm-Draeger P.M. Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation. Med. Klin. (Munich). 90:1995;383-389.
14. Barbarosa J., Steffes M.W., Sutherland D.E., Connett J.E., Vankateswara R., Mauer M. Effect of glycemic control on early diabetic renal lesions. J. Am. Med. Assoc. 272:1994;600-606.
15. Fioretto P., Steffes M.W., Sutherland D.E., Mauer M. Sequential renal biopsies in insulin-dependent diabetic patients: Structural factors associated with clinical progression. Kidney Int. 48:1995;1929-1935.
16. Microalbuminuria in type 1 diabetic patients. Diabetes Care. 15:1992;495-501.
17. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Br. Med. J. 311:1995;973-977.
18. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br. Med. J. 306:1993;1235-1239.
19. Damsgaard E.M., Frøland A., Jørgensen O.D., Mogensen C.E. Mortality in newly diagnosed fasting hyperglycaemics is strongly associated with urinary albumin excretion. Diabetologia. 34(2):1991;10.
20. Gilbert R., Tsalamandris C., Bach L. et al. Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int. 44:1993;855-859.
21. Knöbl P., Schernthaner G., Schnack Ch. et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36:1993;1045-1050.
22. Equiluz-Bruck S., Schnack Ch., Kopp H.P., Schernthaner G. Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am. J. Hypertens. 9:1996;1139-1143.
23. Coonrod B.A., Ellis D., Becker J. et al. Predictors of microalbuminuria in individuals with IDDM. Diabetes Care. 16:1993;1376-1383.
24. Schnack Ch., Hoffmann W., Hopmeier P., Schernthaner G. Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. Diabetologia. 39:1996;1611-1616.
25. Schmitz A., Pedersen M.M., Hansen K.W. Blood pressure by 24 h ambulatory recordings in type II (non-insulin dependent) diabetics: relationship to urinary albumin excretion. Diabetes Metab. 17:1991;301-307.
26. Nielsen S., Schmitz A., Rehling M., Mogensen C.E. Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type-II diabetes. Diabetes Care. 16:1993;1427-1432.
27. Foster D.W. Insulin resistance-a secret killer? New Engl. J. Med. 320:1989;733-734.
28. Jarret R.J. In defence of insulin: a critique of syndrome X. Lancet. 340:1992;469-471.
29. Schnack Ch., Pietschmann P., Knöbl P., Schuller E., Prager R., Schernthaner G. Apolipoprotein (a) levels and atherogenic lipid fractions in relation to the degree of urinary albumin excretion in type-2 diabetes mellitus. Nephron. 66:1994;273-277.
30. Bruckert E., Davidoff P., Grimaldi A. et al. increased serum levels of lipoprotein (a) in diabetes mellitus and their reduction with glycemic control. J. Am. Med. Assoc. 263:1990;35-36.
31. Haffner S.M., Tuttle K.R., Rainwater D.L. Decrease of lipoprotein (a) with improved glycemic control in IDDM subjects. Diabetes Care. 14:1991;302-307.
32. Ritter M.M., Richter W.O., Lyko K., Schwandt P. Lp(a) serum concentrations and metabolic control. Diabetes Care. 15:1992;1441-1442.
33. Schernthaner G. Microalbuminuria in non-insulin-dependent diabetes mellitus. Mogensen C-E. Microalbuminuria. A Marker for Organ Damage. 1996;28-40 Science Press.